Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin -: Reply

被引：0
|
作者：
Griffiths, PD [1 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 03期
关键词：
D O I：
10.1093/jac/dkf149
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Macrolide Resistance in Streptococcus pyogenes: A Marker of an Overuse of Macrolides Reply
    Liu, Xiaorong
    Yang, Yonghong
    [J]. PEDIATRIC PULMONOLOGY, 2009, 44 (12) : 1248 - 1249
  • [22] Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes
    Jasir, A
    Schalén, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 135 - 137
  • [23] In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms
    McGhee, Pamela
    Clark, Catherine
    Kosowska-Shick, Klaudia M.
    Nagai, Kensuke
    Dewasse, Bonifacio
    Beachel, Linda
    Appelbaum, Peter C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 230 - 238
  • [24] Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain
    Portillo, A
    Lantero, M
    Gastañares, MJ
    Ruiz-Larrea, F
    Torres, C
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1999, 13 (02) : 137 - 140
  • [25] GENETICS OF RESISTANCE TO MACROLIDE ANTIBIOTICS AND LINCOMYCIN IN NATURAL ISOLATES OF STREPTOCOCCUS-PYOGENES
    MALKE, H
    [J]. MOLECULAR & GENERAL GENETICS, 1974, 135 (04): : 349 - 367
  • [26] Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates
    Schmitz, FJ
    Perdikouli, M
    Beeck, A
    Verhoef, J
    Fluit, AC
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (05) : 433 - 436
  • [27] Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016
    Muhtarova, Adile A.
    Gergova, Raina T.
    Mitov, Ivan G.
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 10 : 238 - 242
  • [28] Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain:: Mechanisms of resistance and clonal diversity
    Albertí, S
    Cortés, G
    García-Rey, C
    Rubio, C
    Baquero, F
    García-Rodríguez, JA
    Bouza, E
    Aguilar, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) : 418 - 420
  • [29] Increasing telithromycin resistance among Streptococcus pyogenes in Europe
    Richter, Sandra S.
    Heilmann, Kristopher P.
    Dohrn, Cassie L.
    Beekmann, Susan E.
    Riahi, Fathollah
    Garcia-de-Lomas, Juan
    Ferech, Matus
    Goossens, Herman
    Doern, Gary V.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 603 - 611
  • [30] Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary
    Gattringer, R
    Sauermann, R
    Lagler, H
    Stich, K
    Buxbaum, A
    Graninger, W
    Georgopoulos, A
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (03) : 290 - 293
12345